81445 So neo gsap 5-50dna/dna & rna
Also known as: somatic tumor panel, cancer gene sequencing, comprehensive tumor analysis
Somatic oncology gene sequence analysis panel including 5-50 genes analyzing DNA and RNA.
In Plain Language
cancer tumor gene test; genetic test of cancer cells
Clinical Context
Identifies somatic mutations in tumor tissue for cancer prognosis, treatment selection, and targeted therapy eligibility.
RVU Information
CPT 81445 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81445?
CPT 81445 (So neo gsap 5-50dna/dna & rna) is a Pathology & Lab code. Somatic oncology gene sequence analysis panel including 5-50 genes analyzing DNA and RNA.
Who uses CPT code 81445?
CPT 81445 is used by oncology, molecular pathology, pathology. Identifies somatic mutations in tumor tissue for cancer prognosis, treatment selection, and targeted therapy eligibility.
When is CPT 81445 used?
Identifies somatic mutations in tumor tissue for cancer prognosis, treatment selection, and targeted therapy eligibility.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.